SpringWorks Therapeutics Inc (SWTX)

SpringWorks Therapeutics Inc (SWTX) 最新ニュース

SpringWorks Therapeutics to Participate in the BofA Securities 2024 Health Care Conference

GlobeNewswire Inc.

SpringWorks Therapeutics (SWTX) Reports Q1 Loss, Tops Revenue Estimates

Zacks Investment Research

SpringWorks Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Business Updates

GlobeNewswire Inc.

SpringWorks Therapeutics Announces Abstracts Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire Inc.

SpringWorks Therapeutics to Report First Quarter 2024 Financial Results Thursday, May 2, 2024

GlobeNewswire Inc.

SpringWorks Therapeutics Initiates Rolling Submission of New Drug Application to the FDA for Mirdametinib for the Treatment of Children and Adults with NF1-PN

GlobeNewswire Inc.

SpringWorks Therapeutics Announces European Medicines Agency Validation for Marketing Authorization Application of Nirogacestat for the Treatment of Adults with Desmoid Tumors

GlobeNewswire Inc.

SpringWorks Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business Updates

GlobeNewswire Inc.

SpringWorks Therapeutics to Present at Upcoming Investor Conferences

GlobeNewswire Inc.

Immunome (IMNM) to Acquire Desmoid Tumor Candidate, Stock Up

Zacks Investment Research

SpringWorks Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

GlobeNewswire Inc.

SpringWorks (SWTX) Surges More Than 80% in 3 Months: Here's Why

Zacks Investment Research

SpringWorks Therapeutics Highlights 2023 Accomplishments and Anticipated Milestones for 2024 at the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire Inc.

SpringWorks Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire Inc.

SpringWorks Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

GlobeNewswire Inc.

SpringWorks Therapeutics Announces Pricing of Upsized Public Offering of Common Stock

GlobeNewswire Inc.

SpringWorks Therapeutics Announces Proposed Public Offering of Common Stock

GlobeNewswire Inc.

Why Titan Machinery Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Benzinga

La-Z-Boy Posts Upbeat Earnings, Joins Victoria's Secret, Snowflake And Other Big Stocks Moving Higher On Thursday

Benzinga

SpringWorks (SWTX) Rises on FDA Nod for Desmoid Tumor Drug

Zacks Investment Research

Analyst Ratings for SpringWorks Therapeutics

Benzinga

SpringWorks Therapeutics to Participate in the 6th Annual Evercore ISI HealthCONx Conference

GlobeNewswire Inc.

Why SenesTech Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Benzinga

SpringWorks stock on track for record gain after FDA approves first treatment for rare type of aggressive tumors

MarketWatch

PDD Posts Upbeat Revenue, Joins Avidity Biosciences, SpringWorks Therapeutics And Other Big Stocks Moving Higher On Tuesday

Benzinga

SpringWorks Therapeutics shares jump after FDA approves first treatment for rare type of aggressive tumors

MarketWatch

Why SpringWorks Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

Benzinga

SpringWorks Therapeutics Announces FDA Approval of OGSIVEO™ (nirogacestat) as the First and Only Treatment for Adults with Desmoid Tumors

GlobeNewswire Inc.

HC Wainwright & Co. Maintains Buy Rating for SpringWorks Therapeutics: Here's What You Need To Know

Benzinga

SpringWorks (SWTX) Falls Despite Positive Mirdametinib Study Data

Zacks Investment Research

SpringWorks Therapeutics Announces Positive Topline Results from the Phase 2b ReNeu Trial of Mirdametinib in NF1-PN

GlobeNewswire Inc.